-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SwXduIM/ZHkXBgdNoduLA0yhdn+hktnbOjPo08cz8AGNXdsB+dCtKCy+Rw0dQpkN lYRD471djgRT4b8NVfQP5A== 0000878088-10-000041.txt : 20100723 0000878088-10-000041.hdr.sgml : 20100723 20100723093619 ACCESSION NUMBER: 0000878088-10-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100721 FILED AS OF DATE: 20100723 DATE AS OF CHANGE: 20100723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tropiano Michael A CENTRAL INDEX KEY: 0001493845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 10966193 MAIL ADDRESS: STREET 1: C/O PAR PHARMACEUTICAL COMPANIES, INC. STREET 2: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-07-21 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001493845 Tropiano Michael A C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07960 0 1 0 0 Executive Vice President & CFO Common Stock 2010-07-21 4 A 0 7179 0 A 30597 D Award of shares of Restricted Stock under the Company's 2004 Performance Equity Plan. 25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary until fully vested. The closing price of the Company's Common Stock as reported by The New York Stock Exchange on the date of grant was $27.86. Includes (i) 1,563 shares of Common Stock, and (ii) 29,034 shares of Restricted Stock and Restricted Stock Units, held by Mr. Tropiano. /s/ Marian E. Gustafson for Michael A. Tropiano 2010-07-23 -----END PRIVACY-ENHANCED MESSAGE-----